DOI: 10.1055/s-00000161

The Journal of Knee Surgery

References

Perzborn E, Kubitza D, Misselwitz F.
Rivaroxaban. A novel, oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of thromboembolic disorders.

Hamostaseologie 2007;
27 (04) 282-289

Perzborn E, Kubitza D, Misselwitz F.
Rivaroxaban. A novel, oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of thromboembolic disorders.

Hamostaseologie 2007;
27 (04) 282-289

Download Bibliographical Data

Search in:
Access: